0.3280
0.0000
(0.00%)
As of January 30 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-65,944.6710
-65,944.6710
-45,186.2790
-32,205.2660
-34,929.4850
Investing Cash Flow
--
--
--
--
668.3680
Financing Cash Flow
28,176.9530
28,176.9530
62,534.6220
70.1160
1,002.5600
End Cash Position
17,820.8270
17,820.8270
56,333.0850
39,674.4130
71,034.9830
Interest Paid Supplemental Data
14.3700
14.3700
16.4160
28.6330
37.7220
Capital Expenditure
--
--
--
--
-31.6320
Issuance of Capital Stock
30,116.9020
30,116.9020
65,987.6410
--
1,020.7330
Issuance of Debt
1,895.9070
--
416.3410
205.2880
103.6750
Repurchase of Capital Stock
-1,837.6140
-1,837.6140
-3,764.8710
--
--
Free Cash Flow
-65,944.6710
-65,944.6710
-45,186.2790
-32,205.2660
-34,961.1170
6/30/2021 - 5/10/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BOVNF BioInvent International AB (publ)
4.7000
0.00%
GNNSF Genscript Biotech Corporation
1.3550
0.00%
SNBIF SanBio Company Limited
4.6500
0.00%
HNSBF Hansa Biopharma AB (publ)
3.0000
0.00%
MLLCF Molecular Partners AG
4.2200
0.00%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
OXBDF Oxford Biomedica plc
5.56
0.00%
IPHYF Innate Pharma S.A.
2.9000
0.00%
VBIZF Viva Biotech Holdings
0.0950
0.00%
TRGNF Transgene SA
1.5900
0.00%